COVID-19 vaccine induced subacute cutaneous lupus erythematosus
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252552Keywords:
COVID-19, Lupus erythematosus, Systemic, COVID-19 vaccines, Vaccines, Autoimmune diseaseAbstract
It has been documented that COVID-19 vaccinations have been associated with the exacerbation of underlying autoimmune conditions as well as the new onset development of these disorders. In the following case, we present a 60-year-old Caucasian female with no prior documented autoimmune history who developed a blistering rash four days after receiving Moderna’s messenger ribonucleic acid vaccine. Initial laboratory and histopathology findings revealed elevated inflammatory markers and interface dermatitis. Over the course of several weeks, her rash progressed to bleeding and desquamation that covered approximately 80% body surface area. Further workup indicated positive ANA antibody and SS-A/Ro antibody leading to the diagnosis of subacute cutaneous lupus erythematosus (SCLE). She was treated with systems and topical steroids, as well as hydroxychloroquine. Six months post-diagnosis revealed marked improvement of her skin findings. Given the onset of her symptoms in relation to vaccine administration, it is suspected that Moderna’s vaccine may be associated with autoimmune disease onset.
Metrics
References
Pearson DR. Skin signs of systemic disease. In: Soutor C, Hordinsky MK. eds. Clinical Dermatology: Diagnosis and Management of Common Disorders, 2e. McGraw Hill; 2022. Available at: https://accessmedicine-mhmedical-com.proxy.ulib.uits.iu.edu/content.aspx?bookid=3171§ionid=266028605. Accessed on 11 April 2025.
James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM. Cutaneous vascular diseases, Andrews’ Diseases of the Skin, Philadelphia. 2020;35:813-61.
Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010;123(2):183. DOI: https://doi.org/10.1016/j.amjmed.2009.06.030
Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Benvenga S, et al. The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): Review of the literature and report of a large series. Autoimmun Rev. 2019;18(3):287-92. DOI: https://doi.org/10.1016/j.autrev.2018.10.001
Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, et al. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol. 2022;61(10):1187-204. DOI: https://doi.org/10.1111/ijd.16063
Olivieri B, Betterle C, Zanoni G. Vaccinations and autoimmune diseases. Vaccines. 2021;9(8):815. DOI: https://doi.org/10.3390/vaccines9080815
Chen Y, Xu Z, Wang P, Li X-M, Shuai Z-W, Ye D-Q, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunol. 2022;165:386-401. DOI: https://doi.org/10.1111/imm.13443
Patil S, Patil A. Systemic lupus erythematosus after COVID-19 vaccination: A case report. J Cosmet Dermatol. 2021;20(10):3103-4. DOI: https://doi.org/10.1111/jocd.14386
Khanna U, Opera Y, Mir A, Halverstam C. New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature. JAAD Case Rep. 2022;30:30-34 DOI: https://doi.org/10.1016/j.jdcr.2022.09.026
Lemoine C, Padilla C, Krampe N, Doerfler A, Morgenlander A, Thiel B, et al. Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report. Clin Rheumatol. 2022;41:1597-601. DOI: https://doi.org/10.1007/s10067-022-06126-x
Downloads
Published
How to Cite
Issue
Section
